Workplace Wellness Biomarkers: What to Measure and How

Workplace wellness biomarkers are measurable health indicators, such as blood pressure, BMI, cholesterol and blood glucose, that a wellness program collects to give employees a baseline and to track group-level change over time. They screen for risk. They do not diagnose. A well-run program pairs a short questionnaire, a few physical measurements and a blood draw, then routes every result back to a clinician who can interpret it.

If you run a wellness program, a clinic that serves employers, or a research site that tests working adults, this guide covers what to measure, how collection works, what the evidence says about outcomes, and how to protect employee data.

TL;DR

• Common workplace biomarkers are blood pressure, BMI, waist circumference, lipids (cholesterol) and glucose. The first group is measured without blood; the last two need a finger stick or venous draw.
• Screening identifies risk. U.S. guidance says only a credentialed clinician responsible for the patient can diagnose, so results should point employees to their own doctor.
• Evidence on outcomes is mixed. A large randomized trial found no significant change in measured biometrics at 12 and 24 months, so design the program around follow-up, not the screening day alone.
• Under the ADA and GINA, participation must be voluntary, notice must be clear, and employers receive results only in aggregate.
• Choose a lab partner that can handle phlebotomy, specimen pickup, secure results delivery and clear reporting.

What workplace wellness biomarkers are

A biomarker is a measurable indicator of a biological state. In a workplace program the term usually covers the readings gathered during a biometric screening. The American College of Occupational and Environmental Medicine describes biometric screening as measuring physical characteristics such as height, weight, BMI, blood pressure, blood cholesterol, blood glucose and aerobic fitness at the worksite, so employers can benchmark and evaluate changes in employee health over time.

It helps to separate three related terms:

• Health risk appraisal (HRA): a questionnaire. The U.S. Office of Personnel Management (OPM) says the most common worksite screening types are HRAs and biometric testing. An HRA collects self-reported information, identifies risk factors, gives individual feedback and links the person to at least one health-promoting intervention.
• Biometric testing: the measurements and blood tests. OPM says this testing screens for potential medical concerns rather than diagnosing or treating a condition.
• Diagnosis: a clinical judgment made by a provider who knows the patient. Consensus guidance published in the Journal of Occupational and Environmental Medicine states that employer-provided screenings are not appropriate for diagnosing disease.

Keeping those three apart shapes everything else: how you word employee communications, what the lab report says, and who sees what.

Which biomarkers programs usually measure

Most programs start with a small, well-understood set. The same consensus statement describes workplace screenings as commonly having three components: an HRA with lifestyle data, biometric measurements that need no blood, and blood testing that commonly includes cholesterol or lipid levels and glucose.

Non-blood measurements

The same guidance lists height, weight, calculated BMI, waist and hip circumference, body composition, blood pressure and pulse rate as typical non-blood measurements. These are quick, need no lab and are easy to repeat.

Blood-based markers

Blood testing adds the markers most programs care about:

OPM’s fact sheet lists biometric testing as covering blood pressure, cholesterol, diabetes and obesity (BMI). A single abnormal reading is a prompt for a conversation with a clinician, not a conclusion.

Programs that want a wider view sometimes add further blood markers. If you are designing a broader panel for a wellness program, our wellness panels and lipid testing pages show the kind of testing we support, and our list of what we test is the place to start when you are matching markers to program goals.

How screenings are conducted

A typical screening day follows a simple sequence.

1. Questionnaire. Employees complete an HRA, ideally before the event, so the results can be read in the context of their lifestyle answers.
2. Physical measurements. Staff record height, weight, waist circumference, blood pressure and pulse.
3. Blood collection. Published guidance notes two main routes: a finger stick with point-of-care testing, or a venous draw with specimens sent to a laboratory. Some tests also use finger-stick blood collected on a card or device and shipped to a lab.
4. Results delivery. Each employee receives an individual report. The employer sees only de-identified, aggregate data.
5. Follow-up. Employees with out-of-range values are encouraged to see their own clinician. Those without a clinician are connected to one.

Finger stick or venous draw?

Finger-stick testing is fast and gives results on the spot, which suits an event with high traffic. A venous draw processed in a clinical laboratory suits programs that want a fuller panel from one sample, structured electronic reporting and a clear chain of custody for the specimen. Which one fits depends on the markers you want and on how you plan to use the data. If your program uses a venous draw, mobile phlebotomy and scheduled specimen pickup remove most of the logistics from your team’s plate. Our preventive health testing playbook walks through how we think about structuring that kind of program.

What the evidence says about outcomes

It is worth being clear-eyed about outcomes, because that is what makes a program worth funding and worth improving.

In a U.S. randomized trial of a comprehensive workplace wellness program at the University of Illinois at Urbana-Champaign, researchers found no significant effects on measured biometrics, medical diagnoses or medical use after 12 and 24 months. The same study did report positive changes: improved employee health beliefs, and a higher share of employees reporting that they had a primary care physician at 24 months.

A separate retrospective claims analysis covering 2011 to 2015 looked at a program that offered premium discounts for completing biometric screenings and meeting goals. It found significant reductions in total medical cost (14.2%) and emergency department visits (11.2%) only in a subgroup that enrolled or met goals in some years but not all. It detected no significant impact among employees who enrolled and met goals in every year.

What does this mean in practice? Three things:

• Connection to primary care is a worthwhile aim in its own right. The Illinois result on primary care physician access is one concrete, achievable outcome.
• Screening works best as part of a larger health management effort. Occupational guidance describes screenings as part of an overall program used for secondary prevention, meaning screening and early detection, with baselines that help evaluate changes over time.
• Follow-up matters as much as measurement. A number with no next step does little. A number paired with a referral, a retest and a coaching option gives employees something to act on.

Using results well

The single most useful rule is the one every source repeats: screening results identify risk factors and should not be treated as a diagnosis. Employees should be directed to clinicians for interpretation in a clinical context.

Put that into the program design:

• Write it on the report. Individual reports should say plainly that the screening is not a substitute for a regular medical exam or wellness visit, and that anyone with an out-of-range value should talk to their own clinician.
• Confirm before concluding. A single reading is a snapshot. Abnormal values are best confirmed by a clinician, who can order repeat testing and weigh the result against history and symptoms.
• Evaluate at the group level. Employers can compare aggregate baselines with later screenings to see whether risk factors in the workforce are shifting, while individual results stay private.
• Offer a path for people without a doctor. Equal access matters. Employees who lack a primary care provider, work remote or night shifts, or cannot easily attend an event need an alternative way to take part, such as a lab visit or mobile collection.

Limits to plan for

Because screenings flag risk rather than diagnose, a program should expect some results that need clinical follow-up and some employees who will find the process uncomfortable. Planning for that is part of a good design: offer a private setting, allow opt-out, give employees time to read their report, and make the referral path obvious. Consistent collection methods and a qualified laboratory also help keep results comparable from year to year.

Consent, confidentiality and the law

Health data collected at work carries legal obligations in the U.S. The Equal Employment Opportunity Commission (EEOC) explains that the ADA and GINA generally prohibit employers from obtaining and using information about employees’ health conditions or those of family members, but allow health-related questions and medical exams, including biometric screenings, when they are part of a voluntary wellness program that provides health or genetic services.

Under the same final rules, which took effect in 2017:

• Employers may receive wellness program information only in aggregate terms.
• Participating employees must receive a notice describing what information will be collected, with whom it will be shared and why, the limits on disclosure, and how confidentiality will be maintained.
• GINA includes its own notice and consent provisions for health and genetic services offered to employees and family members.
• Employers may not require employees or family members to agree to the sale, exchange, transfer or disclosure of their health information as a condition of participating or earning an incentive.

The rules also address incentives. The 2016 final rules tied permitted incentives to 30% of the cost of self-only coverage for programs that are part of a group health plan, and limited spouse incentives to the same cap. Incentive limits have been revisited since, so confirm current EEOC guidance with employment counsel before you set any reward.

On the data side, anyone handling identifiable results needs a clear privacy plan covering storage, access and vendor agreements. This overview of HIPAA compliance considerations shows how health information handling expectations apply to a provider’s day-to-day operations, and the same discipline applies when a lab handles your employees’ results. Whether HIPAA applies to a given program depends on how it is structured, so ask your counsel.

Perspective

We see workplace wellness biomarkers as a data quality and logistics question first. A screening only helps if the specimen is collected properly, tested in a clinical laboratory, and reported quickly in a form that employees and their clinicians can use.

That is why we build around the full path: phlebotomy, courier specimen pickup, a broad test menu, electronic results reporting, a provider portal and integration with the systems practices already use. Our approach is designed to reduce the burden on HR teams and on the clinics that support them.

We also believe in keeping the message simple for employees. Biomarkers show where a conversation with a clinician should start. When the report is clear and the next step is obvious, a screening becomes the first step toward better care instead of a number on a page.

Kohealth Labs

A practical checklist for choosing a lab partner

Whether you are an employer, a wellness vendor, or a clinic running screenings for local companies, these questions help you compare options:

• Collection model. Can the lab provide venous phlebotomy on site or through mobile collection, and handle specimen transport?
• Menu. Does it cover the core markers (lipids, glucose) and let you add others as the program matures?
• Turnaround. How quickly are results available, and how are they delivered?
• Reporting. Are results available electronically, with options for integration into your clinic’s records or a wellness platform?
• Privacy. How does the lab keep identifiable results separate from what the employer sees, and how does it support the notice and consent requirements above?
• Follow-up. Is there a route for employees to get repeat testing or a clinician visit after an abnormal result?
• Support. Will you have a named contact who answers quickly during setup and after launch?

Clinics that run recurring retest cycles may also find our guide to functional medicine lab panels and retesting useful for planning the follow-up window.

Work with KoHealth Labs on your wellness program

We are a diagnostic laboratory serving physicians, practices, wellness programs, telehealth platforms, research organizations and other healthcare organizations. Our services include clinical laboratory testing, mobile phlebotomy, specimen pickup and transportation, electronic results reporting and LIS integration, with panels spanning 100+ biomarkers.

If you are building or reworking a biomarker program, we can help you match the panel to your goals and set up collection and reporting. Tell us about your population and timeline at KoHealth Labs.

For research-led programs, our clinical trials laboratory services describe how we handle study-specific testing and specimen logistics.

FAQ

Are workplace biometric screenings a diagnosis?

No. U.S. occupational guidance states that screenings identify risk factors that may signal existing or potential disease, and that only an appropriately credentialed provider responsible for the patient can diagnose. Employees with out-of-range results should see their own clinician.

Which biomarkers are most common in workplace wellness programs?

Blood pressure, BMI, waist circumference, cholesterol (lipids) and blood glucose are the most common. Programs often start there and add markers later based on the needs of the workforce and the advice of a medical director.

Can employers see individual employee results?

Under the EEOC’s ADA and GINA wellness rules, employers receive wellness program information only in aggregate terms. Employees must also get a notice explaining what is collected, who sees it, and how it is kept confidential.

Does biomarker screening improve employee health?

The evidence is mixed. A randomized trial at the University of Illinois found no significant change in measured biometrics at 12 and 24 months, though it did find better health beliefs and more employees with a primary care physician. Programs with strong follow-up are better positioned to turn results into action.

Sources

• Biometric Health Screening for Employers (ACOEM position statement)
• OPM: Workplace Health Screenings
• OPM: Common Screenings
• Biometric Health Screening for Employers: consensus statement (JOEM)
• Biometric Health Screening for Employers (JOEM, full text)
• Effects of a Workplace Wellness Program on Employee Health (PubMed)
• An Analysis of a Biometric Screening and Premium Discount Program (Population Health Management)
• EEOC Issues Final Rules on Employer Wellness Programs

For more information about our diagnostic testing, clinical research laboratory services, or partnership opportunities, visit https://kohealthlabs.com or contact KoHealth Labs at (469) 792-8439 and ask for Amy Patterson.